Important Announcement

20 August, 2020 at 10:27 AM

Visit Back2BU for the latest updates and information on BU's response to COVID-19. Students can find additional information in the Undergraduate Student Guide and Graduate & Professional Student Guide.

Skip to Main Content
Boston University School of Medicine: Hematology & Medical Oncology

  • About Us
  • Faculty
  • Clinical Program
  • Research Program
  • Fellowship Program
Search
  • About Us
  • Resources
  • Clinical Program
  • Research Program
  • Fellowship Program
  • Resources
  • Clinical Faculty Time Off Requests
  • Faculty/Staff Reimbursement Requests
  • Job Opportunities
  • Contact Us

Clinical Trials

  • COVID-19
  • All Cancers
  • AIDS Malignancies
  • Amyloidosis
  • Breast Cancer
  • Cutaneous Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecological Cancer
  • Head & Neck Cancer
  • Leukemia/Lymphoma
  • Lung Cancer
  • Multiple Myeloma
  • Sickle Cell Disease

Related to Clinical Trials

More about Hematology & Medical Oncology

Quick Links

  • BMC
  • BUSM
  • Contact Us
  • Department of Medicine

Faculty Publications

Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen

Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis

AL Amyloidosis in Myeloma: Red Flag Symptoms

Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment

Newsletter

September 2020

August 2020

Boston University
Boston University Medical Center
© Boston University. All rights reserved. www.bu.edu